Skip to main content
logo
argenx SE (ARGNF)
OTCMKTS · Delayed Price · Currency is USD
786.05
-47.45 (-5.69%)
At close: Oct 30, 2025

argenx SE Revenue

argenx SE had revenue of $1.15B in the quarter ending September 30, 2025, with 95.51% growth. This brings the company's revenue in the last twelve months to $3.68B, up 92.98% year-over-year. In the year 2024, argenx SE had annual revenue of $2.25B with 77.22% growth.

Revenue (ttm)
3.68B
Revenue Growth
+92.98%
P/S Ratio
13.52
Revenue / Employee
2.30M
Employees
1,599
Market Cap
49.81B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.25B979.61M77.22%
Dec 31, 20231.27B827.58M187.66%
Dec 31, 2022441.01M-87.25M-16.52%
Dec 31, 2021528.27M466.31M752.59%
Dec 31, 202061.96M-30.85M-33.24%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Jushi Holdings256.36M
Glass House Brands221.55M
Elite Pharmaceuticals105.45M
Silence Therapeutics27.17M
China New Energy Group Co.12.51M
Northwest Biotherapeutics1.09M
Revenue Rankings

argenx SE News

More News